This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The product will be launched in March 2024
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
BHL will undertake the development and supply of these molecules
_in_Mizushima,_Japan_256_384.jpg)
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
The facility will accommodate over 1,500 employees
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
The observations do not pose any risk to site's compliance standards or its business continuity
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Subscribe To Our Newsletter & Stay Updated
